Epigenetic analysis of hepatocellular carcinoma development : involvement of HBV-modulated DNA methylation
Hepatocellular carcinoma (HCC) is one of the most aggressive human malignancies. Epidemiological studies have shown that HCC is closely associated with chronic hepatitis B virus (HBV). However, the underlying mechanisms of the HBV-associated HCC development remain unclear. DNA methylation, one of th...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Theses and Dissertations |
| Language: | English |
| Published: |
2010
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/10356/40634 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | Nanyang Technological University |
| Language: | English |
| Summary: | Hepatocellular carcinoma (HCC) is one of the most aggressive human malignancies. Epidemiological studies have shown that HCC is closely associated with chronic hepatitis B virus (HBV). However, the underlying mechanisms of the HBV-associated HCC development remain unclear. DNA methylation, one of the mechanisms in epigenetics, affects gene expression at the transcriptional level. Evidence has revealed the association between HCC and HBV-mediated DNA methylation. Within the four proteins encoded by HBV genome, the HBV X protein (HBx) has been found to epigenetically inhibit some tumor suppressor genes (TSGs), which may lead to development of HCC. To investigate comprehensively the role of HBV/HBx in DNA methylation, a protein profile affected by HBV in HBV-producing HepG2.2.15 cells compared with HepG2, was analyzed by our iTRAQ-coupled 2-D LC/MS-MS analysis. Fifteen proteins including S100A6 and ANXA2 were identified. A role of these proteins as target of HBV-mediated DNA methylation was supported by validation assays, including their re-activation in cells treated with 5-Aza-dC (a DNA methyltransferase inhibitor). DNA methylation analysis suggested that, the proteins were down-regulated by HBV via DNA hypermethylation. |
|---|